Celldex Therapeutics reported $174K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aptinyx Inc APTX:US $ 0 0
Celldex Therapeutics CLDX:US $ 0.17M 0.16M
Cytrx CYTR:US 0 0
Immunogen IMGN:US $ 38.08M 10.09M
Nektar Therapeutics NKTR:US $ 25.01M 0.09M
Newlink Genetics NLNK:US $ 0.11M 0.11M
Northwest Biotherapeutics NWBO:US 0 350K